By Nancy Lapid April 10 (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to ...
The reason some people on weight-loss jabs shed pounds more easily than others may be because of their DNA, scientists have ...
Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...
A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...
Genes may predict GLP-1 weight loss, linking genetic variants to treatment response and side effects in 27,885 patients using GLP-1 drugs.
PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, ...
Structural variants (SVs) are alterations in the DNA sequence that involve large-scale changes, typically longer than 50 base pairs. Advances in long-read sequencing have significantly increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results